NCT05619835

Brief Summary

The aim of the study is to analyze the applicability (usability) of a tele-health service as part of a potential disease management program for patients with peripheral arterial disease. The following investigations will be conducted as part of the usability study. In the context of a tele-health service, knowledge, physical condition (including walking distance) will be documented during face-to-face and televisits, dislocated supervised gait training and education will be provided, and satisfaction with the tele-health service will be evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

November 11, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 17, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2023

Completed
Last Updated

November 1, 2023

Status Verified

October 1, 2023

Enrollment Period

10 months

First QC Date

May 7, 2022

Last Update Submit

October 31, 2023

Conditions

Keywords

Peripheral Arterial DiseaseWalking exerciseTele-health ServiceDisease Management ProgramPreventive MedicineIntegrated careVascular Medicine

Outcome Measures

Primary Outcomes (1)

  • Patient satisfaction with the telehealth service.

    Study participants will undergo guided interviews measuring patient satisfaction with telehealth service.

    At time point visit 3, which is 12 weeks after baseline

Secondary Outcomes (8)

  • Proportion of patients, who would be satisfied with the telehealth service if telephone calls would not be provided by a nurse during the programme

    At time point visit 3, which is 12 weeks after baseline

  • Change of walking distances in the 6 minute walk test determined by the certified nursing staff in response to the telehealth service.

    From baseline to visit 3, which is 12 weeks after baseline

  • Change of subjective limitations in the activities of daily living.

    From baseline to visit 3, which is 12 weeks after baseline

  • Change of knowledge about peripheral arterial disease.

    From baseline to visit 3, which is 12 weeks after baseline

  • Total number of performed 6 minute walk tests during the telehealth service.

    At time point visit 3, which is 12 weeks after baseline

  • +3 more secondary outcomes

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with IIa and IIb PAD at the Department of Angiology at the LKH-University Hospital Graz.

You may qualify if:

  • Documented diagnosis of "peripheral arterial occlusive disease" in, IIa and IIb (according to Fontaine).
  • Age between 18 and 80 years
  • Written informed consent
  • Smartphone with Android operating system
  • Understanding of how to use the tele-health service

You may not qualify if:

  • Patients with PAD stages I, III and IV (according to Fontaine)
  • Lack of compliance
  • Smartphone with non-Android operating system or incompatible software

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Graz

Graz, Styria, 8036, Austria

Location

MeSH Terms

Conditions

Peripheral Arterial Disease

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc.-Prof. Priv.-Doz. Dr.med.univ. et scient.med.

Study Record Dates

First Submitted

May 7, 2022

First Posted

November 17, 2022

Study Start

November 11, 2022

Primary Completion

August 30, 2023

Study Completion

August 30, 2023

Last Updated

November 1, 2023

Record last verified: 2023-10

Locations